Successful Elimination of SARS-CoV-2 Following Vaccination with BNT162b2 after Prolonged Viral Infection in an Immunocompromised Lymphoma Patient

A 52-year-old man with mantle cell lymphoma treated with bendamustine and rituximab developed prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Despite elevated titers of anti-spike IgG antibody, protracted pancytopenia persisted for more than six months. Finally, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagihara, Masao, Imai, Yui, Uchida, Tomoyuki, Ohara, Shin, Inoue, Morihiro, Sugi, Tomiyuki, Mitamura, Keiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381351/
https://www.ncbi.nlm.nih.gov/pubmed/35850990
http://dx.doi.org/10.2169/internalmedicine.9513-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381351/
https://www.ncbi.nlm.nih.gov/pubmed/35850990
http://dx.doi.org/10.2169/internalmedicine.9513-22

Ejemplares similares